Ibandronate or ibandronic acid
- Level
- Commodity
- Parent
- 51182400
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51182423This classification denotes a bone resorption inhibitor and biphosphonate with the molecular formula C9H23NO7P2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UMD7G2653W, chemically known as phosphonic acid, (1-hydroxy-3-(methylpentylamino)propylidene)bis- but generally known as ibandronic acid, which bears US NIH Compound Identifier 60852. European Medicines Agency schedules Ibandronic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08092MIG. The term IBANDRONIC ACID is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 9, No. 3, 1995, List 35). World Health Organization schedules ibandronic acid in its Anatomical Therapeutic Chemical (ATC) Classification. Ibandronate or ibandronic acid bears US NLM identifiers UMLS ID C0379200 and NCI Concept Code C65874. SMILES: P(=O)(O)(O)C(P(=O)(O)O)(O)CCN(CCCCC)C.
Same parent
Under 51182400 · 28Activities that produce or sell this
KBLI · 8Inherited from family 51180000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.